Publication rates of registered strabismus trials from ClinicalTrials.gov

Leo Meller; Angel Bert Sambo; Nam Nguyen; Shira L Robbins; David B Granet

doi:10.1016/j.jaapos.2024.103936

Publication rates of registered strabismus trials from ClinicalTrials.gov

J AAPOS. 2024 May 9:103936. doi: 10.1016/j.jaapos.2024.103936. Online ahead of print.

Authors

Leo Meller¹, Angel Bert Sambo¹, Nam Nguyen², Shira L Robbins¹, David B Granet³

Affiliations

¹ Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California.
² University of California, San Diego, La Jolla, California.
³ Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California. Electronic address: dgranet@health.ucsd.edu.

PMID: 38729255
DOI: 10.1016/j.jaapos.2024.103936

Abstract

Presently, little is known regarding the characteristics and publication rates of registered strabismus trials from ClinicalTrials.gov. We queried registered strabismus trials that were completed prior to January 1, 2021, from ClinicalTrials.gov. Publication of trials in peer-reviewed journals was confirmed using PubMed.gov, ClinicalTrials.gov, and Google Scholar. Of the 117 trials found, only 69 (59%) were published with a publication delay of nearly 2.5 years. Interventional trials were associated with publication status compared with observational trials. The low publication rates and significant publication delay indicate potential bias in information dissemination of completed strabismus trials.

Publication types

Case Reports